Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIndivior Regulatory News (INDV)

  • There is currently no data for INDV

Director/PDMR Shareholding

20 Nov 2023 12:56

RNS Number : 0206U
Indivior PLC
20 November 2023

INDIVIOR PLC (THE 'COMPANY')

NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES ('PDMR') AND PERSONS CLOSELY ASSOCIATED WITH THEM

The Company announces that it received notification on November 17, 2023 that Mark Stejbach, aNon-Executive Director of the Company, acquired 3,000 shares at an average price of US$16.70 per share on November 17, 2023.

Following this transaction, Mark Stejbach has an interest in 12,684 shares in the Company.

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Mark Stejbach

2

Reason for the notification

a)

Position/status

Non-Executive Director

b)

Initial notification /Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Indivior PLC

b)

LEI

213800V3NCQTY7IED471

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary Shares of US$0.50

CUSIP NO. G4766E 11 6

b)

Nature of the transaction

Purchase of shares

c)

Price(s) and volume(s)

Price(s)

Volume(s)

US$16.70

3,000

d)

Aggregated information

- Aggregated volume

- Price

N/A

e)

Date of the transaction

November 17, 2023

f)

Place of the transaction

Nasdaq Global Select Market

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
DSHPPGCAGUPWGPU
Date   Source Headline
10th Feb 20237:00 amRNSTransaction in Own Shares
9th Feb 20237:00 amRNSTransaction in Own Shares
8th Feb 20237:00 amRNSTransaction in Own Shares
7th Feb 20237:00 amRNSTransaction in Own Shares
6th Feb 20231:00 pmRNSHSR Period for Opiant Acquisition Expires
6th Feb 20237:00 amRNSTransaction in Own Shares
3rd Feb 20237:00 amRNSTransaction in Own Shares
2nd Feb 20237:00 amRNSTransaction in Own Shares
1st Feb 20239:14 amRNSTotal Voting Rights
1st Feb 20237:00 amRNSTransaction in Own Shares
31st Jan 20237:00 amRNSTransaction in Own Shares
30th Jan 20237:00 amRNSTransaction in Own Shares
27th Jan 20233:22 pmRNSHolding(s) in Company
27th Jan 20237:00 amRNSTransaction in Own Shares
26th Jan 20237:00 amRNSTransaction in Own Shares
25th Jan 20233:56 pmRNSHolding(s) in Company
25th Jan 20237:00 amRNSTransaction in Own Shares
24th Jan 20234:37 pmRNSTransaction in Own Shares
23rd Jan 20237:00 amRNSTransaction in Own Shares
20th Jan 20239:31 amRNSHolding(s) in Company
20th Jan 20237:00 amRNSTransaction in Own Shares
19th Jan 202311:22 amRNSHolding(s) in Company
19th Jan 20237:00 amRNSTransaction in Own Shares
18th Jan 20233:28 pmRNSHolding(s) in Company
18th Jan 20237:00 amRNSTransaction in Own Shares
17th Jan 20237:00 amRNSTransaction in Own Shares
16th Jan 20237:00 amRNSTransaction in Own Shares
13th Jan 20234:26 pmRNSHolding(s) in Company
13th Jan 20237:00 amRNSTransaction in Own Shares
12th Jan 20232:43 pmRNSHolding(s) in Company
12th Jan 20237:00 amRNSTransaction in Own Shares
11th Jan 20232:30 pmRNSNotice of Results
11th Jan 20237:00 amRNSTransaction in Own Shares
10th Jan 20231:59 pmRNSHolding(s) in Company
10th Jan 20237:00 amRNSTransaction in Own Shares
9th Jan 202312:21 pmRNSHolding(s) in Company
9th Jan 20237:00 amRNSTransaction in Own Shares
6th Jan 20237:00 amRNSTransaction in Own Shares
5th Jan 202312:26 pmRNSHolding(s) in Company
5th Jan 20238:52 amRNSDirector Declaration
5th Jan 20237:00 amRNSTransaction in Own Shares
4th Jan 202310:37 amRNSHolding(s) in Company
4th Jan 20239:18 amRNSTotal Voting Rights
4th Jan 20237:00 amRNSTransaction in Own Shares
3rd Jan 20239:21 amRNSHolding(s) in Company
3rd Jan 20237:00 amRNSTransaction in Own Shares
30th Dec 202212:46 pmRNSHolding(s) in Company
30th Dec 202212:45 pmRNSHolding(s) in Company
30th Dec 202212:44 pmRNSHolding(s) in Company
30th Dec 202212:43 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.